Joylette L. Portlock, Ph.D.
Affiliations: | 2006 | Stanford University, Palo Alto, CA |
Area:
Genetics, Medicine and SurgeryGoogle:
"Joylette Portlock"Parents
Sign in to add mentor| Michele P. Calos | grad student | 2006 | Stanford | |
| (Characterization and development of a phage integrase system for gene therapy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Portlock JL, Keravala A, Bertoni C, et al. (2006) Long-term increase in mVEGF164 in mouse hindlimb muscle mediated by phage phiC31 integrase after nonviral DNA delivery. Human Gene Therapy. 17: 871-6 |
| Keravala A, Portlock JL, Nash JA, et al. (2006) PhiC31 integrase mediates integration in cultured synovial cells and enhances gene expression in rabbit joints. The Journal of Gene Medicine. 8: 1008-17 |
| Chalberg TW, Portlock JL, Olivares EC, et al. (2006) Integration specificity of phage phiC31 integrase in the human genome. Journal of Molecular Biology. 357: 28-48 |
| Portlock JL, Chalberg TW, Olivares EC, et al. (2005) 194. Characteristics of Site-Specific Integration as Mediated by PhiC31 Integrase in the Human Genome Molecular Therapy. 11 |
| Chalberg TW, Ginsburg DS, Kirby PJ, et al. (2004) 814. Integration Sites Used by the PhiC31 Site-Specific Integrase in the Human Genome Molecular Therapy. 9 |
| Keravala A, Nash J, Portlock JL, et al. (2004) 809. PhiC31 Integrase Mediates Site-Specific Genomic Integration in Rabbit Cells and Rabbit Knee Joints Molecular Therapy. 9 |
| Portlock JL, Calos MP. (2003) Site-specific genomic strategies for gene therapy. Current Opinion in Molecular Therapeutics. 5: 376-82 |